Search Medical Condition
Please enter condition
Please choose location

Nagaizumi-cho, Japan Clinical Trials

A listing of Nagaizumi-cho, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (34) clinical trials

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer.

Patients will be randomised in 1:1 ratio to either olaparib or placebo. Randomisation will be stratified by Hormone receptor status (ER and/or PgR positive/HER2 negative versus TNBC), prior neoadjuvant versus adjuvant chemotherapy and prior platinum use for breast cancer. Randomised patients will receive study treatment for up to a maximum ...

Phase

1.48 miles

Learn More »

A Rollover Protocol of Dacomitinib For Patients In Japan

The intention of the study is to allow continued use of dacomitinib in Japan for patients on closed dacomitinib clinical trials and who continue to experience clinical benefit.

Phase

1.48 miles

Learn More »